Altre lingue NexgenRx Inc.

Azioni

NXG

CA65337X1042

Tempo differito Toronto S.E. Altri mercati azionari 21:09:24 21/06/2024			Variaz. 5gg	Var. 1 gen.
0,28 ^CAD	0,00%		0,00%	+27,27%

17/05	NexgenRx Inc. riporta i risultati degli utili per il primo trimestre conclusosi il 31 marzo 2024	CI
16/05	Charles Burns rassegna le dimissioni da Consigliere di NexgenRx Inc.	CI

Altre lingue

Sblocca tutte le notizie: sii il primo a essere informato e reagisci prima dei mercati!

Registrazione 100% gratuita

NexgenRx Inc. Declares Dividend in Respect of All of Its Outstanding Common Shares, Payable on or Before June 30, 2024	14/06
NexgenRx Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	17/05
Charles Burns Tenders Resignation as Director of NexgenRx Inc	16/05
NexgenRx Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	05/04
NEXGENRX INC. Announces the Retirement of Dave Bennett from its Board of Directors	29/12
NEXGENRX Inc Announces Declaration of Dividend, Payable on or Before January 4, 2024	20/12
NexgenRx Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	23/11
NexgenRx Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	21/08/23
NexgenRx Inc. Announces Declaration of Dividend in Respect of All of Its Outstanding Common Shares , Payable on or Before June 30, 2023	15/06/23
NexgenRx's Q1 Profit Falls, Revenue Rises	19/05/23
NexgenRx Inc. Appoints Dave Bennett as New Director	19/05/23
NexgenRx Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	19/05/23
NexgenRx Swings to Loss in Q4	10/04/23
NexgenRx Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	07/04/23
NexgenRx Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	29/11/22
NexgenRx Inc. Announces Dividend on its outstanding common shares, payable on or Before October 10, 2022	23/09/22
NexgenRx Announced Q2 2022 Financial Results	19/08/22
NexgenRx Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	18/08/22
NexgenRx Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022	17/05/22
NexgenRx Inc. Reports Earnings Results for the Full Year Ended December 31, 2021	25/03/22

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue NexgenRx Inc.

Azioni

NXG

CA65337X1042

Altre lingue

Filtri